首页 > 市场调查报告书 > 製药

药物开发临床实验临床开发

市场调查报告书

商品编码

1677773

临床试验基础设施区域市场分析：中东和北非

Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa

出版日期: 2025年03月05日 | 出版商:

BCC Research | 英文 81 Pages | 订单完成后即时交付

价格

简介目录图表

本报告研究了中东和北非的临床试验基础设施市场，并提供了市场概况摘要、市场影响因素和市场机会分析、市场规模趋势和预测、每个主要国家的详细分析以及竞争格局。

全球临床试验市场概览
中东和北非地区
中东和北非不断发展的临床试验产业
基础设施和资源：弥补新兴市场的差距
患者招募潜力：患者群体多样化，招募率高
经济高效
法规环境：协调与在地化
政府支持和投资
地方政策的影响：鼓励临床研究
合作拓展本地网路
新兴趋势：关注精准医疗和罕见疾病
肿瘤学和罕见疾病的需求不断增长
技术进步：临床业务数位化
了解中东和北非的临床试验状况

第三章市场动态

市场动态
市场驱动因素
推动试验可行性的法律规范
增加患者人数以加强招募和多样性
透过技术进步提高业务效率
合作
个性化医疗试验设计
市场挑战
复杂的监管格局
患者招募和保留的局限性
基础设施和场地容量不足
数位技术采用有限
关键治疗领域的竞争
市场机会
监理改革加速核准速度
肿瘤学和罕见疾病的新焦点
透过公私合营加强研究能力
专注于精准医学和基因组学

第四章市场区隔分析

细分市场
市场分析：依赞助商类型
市场分析：按阶段
按服务类型进行的市场分析
按研究类型进行的市场分析
按治疗领域分類的市场分析

第五章新兴市场

埃及
概述
临床试验状况分析
观察
密件抄送建议
沙乌地阿拉伯（KSA）
概述
临床试验状况分析
观察
密件抄送建议
黎巴嫩
概述
临床试验状况分析
观察
密件抄送建议
UAE
概述
临床试验状况分析
观察
密件抄送建议
伊朗
概述
临床试验状况分析
观察
密件抄送建议

第六章俄乌战争影响分析

概述
供应链中断
监管挑战
患者招募和保留
地缘政治风险

第七章竞争格局

概述
竞争格局
国际 CRO 和製药公司
本地 CRO 和代理机构
学术研究所
临床试验产品和服务映射
中东和北非临床试验的最新趋势
BCC的结语

第 8 章附录

简介目录图表

Product Code: HLC304A

This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.

Report Scope

This report analyzes the Middle East and North Africa (MENA) clinical trial markets, using 2023 as a benchmark year, and offers projections for the forecast period from 2024 to 2029, with estimates of compound annual growth rates (CAGR). The report covers many aspects of the market, including clinical advances, economic factors and business considerations, and outlines the market forces impacting the industry and its phases, study types and therapeutic areas. The report segments the clinical trial market into services, solutions and supplies, and examines the regional dynamics influencing the market.

This report excluded Turkey and Israel from its scope because their clinical trial markets are significantly more advanced than other countries in the MENA region. Including these markets would have skewed the analysis and not accurately reflected the opportunities and challenges the rest of the region faces. This approach ensures a focused examination of MENA's emerging clinical trial landscape, which may be more relevant for companies seeking to expand into less mature markets.

Report Includes

Analysis of the Middle East and Northern Africa's (MENA) regional markets for clinical trial infrastructure
Analyses of the market trends, with revenue data for 2023, estimates for 2024, and projected CAGRs through 2029
Estimate of the current market size and revenue prospects, accompanied by a market share analysis by sponsor type, clinical trial phase, service type, study type, therapeutic area, and country
An understanding of the opportunities and progressions in clinical trial studies by some select countries in emerging MENA markets
Facts and figures pertaining to the current market dynamics, advancements in technology, regulations and prospects
Insights of the ripple effects of the Ukraine-Russia war on clinical trial operations, including supply chain disruptions, regulatory challenges, and patient recruitment and retention
Analysis of the industry structure, including stakeholders' market shares, clinical trial product/services mapping, and recent key developments

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Reasons for Doing this Study
Market Summary

Chapter 2 MENA Clinical Trial Industry Outlook

Global Clinical Trial Market Overview
MENA Share
Evolving MENA Clinical Trial Industry
Infrastructure and Resources: Bridging Gaps in Emerging Markets
Patient Recruitment Potential: Diverse Populations and High Recruitment Rates
Cost-Effectiveness
Regulatory Environment: Harmonization and Local Adaptations
Government Support and Investments
Impact of Regional Policies: Incentivizing Clinical Research
Collaborations Expand Regional Networks
Emerging Trends: Focus on Precision Medicine and Rare Diseases
Growing Demand in Oncology and Rare Diseases
Technological Advances: Digitalizing Clinical Operations
Understanding the MENA Clinical Trial Landscape

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Regulatory Frameworks Driving Trial Feasibility
Growing Patient Population Enhancing Recruitment and Diversity
Technological Advances Streamlining Operations
Collaborations
Personalized Medicine Shaping Trial Design
Market Challenges
Complex Regulatory Landscape
Limited Patient Recruitment and Retention
Insufficient Infrastructure and Site Capacity
Limited Adoption of Digital Technologies
Competition for Key Therapeutic Areas
Market Opportunities
Regulatory Reforms Enabling Faster Approvals
Emerging Focus on Oncology and Rare Diseases
Public-Private Partnerships Boosting Research Capacity
Focus on Precision Medicine and Genomics

Chapter 4 Market Segmentation Analysis

Segmentation Breakdown
Market Analysis, by Sponsor Type
Market Analysis, by Phase
Market Analysis, by Service Type
Market Analysis, by Study Type
Market Analysis, by Therapeutic Area

Chapter 5 Emerging Markets

Egypt
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Kingdom of Saudi Arabia (KSA)
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Lebanon
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
United Arab Emirates
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Iran
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations

Chapter 6 Russia-Ukraine War Impact Analysis

Overview
Supply Chain Disruptions
Regulatory Challenges
Patient Recruitment and Retention
Geopolitical Risks

Chapter 7 Competitive Landscape

Overview
Competitive Landscape
International CROs and Pharmaceutical Companies
Local CROs and Institutions
Academic and Research Institutions
Mapping of Clinical Trial Product Services
Recent Developments in Clinical Trials in the MENA Region
Concluding Remarks from BCC

Chapter 8 Appendix

Methodology
Research Steps
Sources
Abbreviations

简介目录图表

List of Tables

Summary Table : MENA Market for Clinical Trials, by Country, Through 2029
Table 1 : MENA Clinical Trial Analysis, by Study Status, Through 2024
Table 2 : Comparison of MENA Clinical Trial Regulations, Through 2024
Table 3 : Comparison of MENA Clinical Trial Regulations, Through 2024
Table 4 : MENA Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 5 : Regulatory Bodies for Conducting Clinical Trials in the MENA Region
Table 6 : Recent Technological Advances in the MENA Clinical Trial Market, 2023 and 2024
Table 7 : Recent Collaborations in the MENA Clinical Trial Market, 2024
Table 8 : Recent Developments in Clinical Trial Infrastructure in MENA, 2023 and 2024
Table 9 : Leading Causes of Death in MENA, by Country, 2021
Table 10 : Recent Developments in the MENA Region, 2023 and 2024
Table 11 : Recent Collaborations in the MENA Region, 2024
Table 12 : Leading MENA Countries for Clinical Trials, by Sponsor Type, Through 2024
Table 13 : MENA Market for Clinical Trials, by Sponsor Type, Through 2029
Table 14 : Leading MENA Countries for Clinical Trials, by Phase, Through 2024
Table 15 : MENA Market for Clinical Trials, by Phase, Through 2029
Table 16 : MENA Market for Clinical Trials, by Service Type, Through 2029
Table 17 : Leading MENA Countries for Clinical Trials, by Study Type, Through 2024
Table 18 : MENA Market for Clinical Trials, by Study Type, Through 2029
Table 19 : MENA Market for Clinical Trials, by Therapeutic Area, Through 2029
Table 20 : Egyptian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 21 : Companies and Research Institutes for Clinical Trials in Egypt
Table 22 : Egyptian Market for Clinical Trials, by Value, Through 2029
Table 23 : Saudi Arabian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 24 : Companies and Research Institutes for Clinical Trials in the KSA
Table 25 : Saudi Arabian Market for Clinical Trials, by Value, Through 2029
Table 26 : Lebanese Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 27 : Companies and Research Institutes for Clinical Trials in Lebanon
Table 28 : Lebanese Market for Clinical Trials, by Value, Through 2029
Table 29 : UAE Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 30 : Companies and Research Institutes for Clinical Trials in UAE
Table 31 : UAE Market for Clinical Trials, by Value, Through 2029
Table 32 : Iranian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 33 : Companies and Research Institutes for Clinical Trials in Iran
Table 34 : Iranian Market for Clinical Trials, by Value, Through 2029
Table 35 : MENA Clinical Trials Product/Services Mapping Analysis
Table 36 : Recent Developments in the MENA Clinical Trial Market, 2020-2024
Table 37 : Information Sources in this Report
Table 38 : Abbreviations Used in this Report

List of Figures

Summary Figure : MENA Market for Clinical Trials, by Country, 2023-2029
Figure 1 : Global Market for Clinical Trials, by Value, 2023-2029
Figure 2 : Share of the Global Clinical Trials Market Value, by Region, 2023
Figure 3 : Key Considerations for MENA Clinical Trials
Figure 4 : Market Dynamics of Clinical Trial Infrastructure in the MENA Region
Figure 5 : Share of Deaths, by Broad Cause, by Country, 2021
Figure 6 : Share of MENA Market for Clinical Trials, by Sponsor Type, 2023
Figure 7 : Share of MENA Market for Clinical Trials, by Phase, 2023
Figure 8 : Share of MENA Market for Clinical Trials, by Service Type, 2023
Figure 9 : Share of MENA Market for Clinical Trials, by Study Type, 2023
Figure 10 : Share of MENA Market for Clinical Trials, by Therapeutic Area, 2023
Figure 11 : Egyptian Market for Clinical Trials, by Value, 2023-2029
Figure 12 : BCC Recommendations for the Egyptian Market for Clinical Trials
Figure 13 : Saudi Arabian Market for Clinical Trials, by Value, 2023-2029
Figure 14 : BCC Recommendations for Saudi Arabian Clinical Trials
Figure 15 : Lebanese Market for Clinical Trials, by Value, 2023-2029
Figure 16 : BCC Recommendations for Lebanese Clinical Trials
Figure 17 : UAE Market for Clinical Trials, by Value, 2023-2029
Figure 18 : BCC Recommendations for the UAE Clinical Trials
Figure 19 : Iranian Market for Clinical Trials, by Value, 2023-2029
Figure 20 : BCC Recommendations for the Iranian Clinical Trials
Figure 21 : Share of MENA Market for Clinical Trials, by Stakeholder, 2024
Figure 22 : Recommendations for Companies Looking to Enter the MENA Clinical Trial Market
Figure 23 : Methodology Used in the MENA Clinical Trial Market